MarketPeel
Insider Trading Intelligence
ER

Elimelech Rosner

HQY
EVP, CHIEF TECHNOLOGY OFFICER · HEALTHEQUITY, INC. · CIK 0001916312
FILING MIX · LIFETIME23%/77%
BUYS
7
SELLS
23
TOTAL VALUE
$19.61M
COMPANIES
1
ACTIVE SINCE
Mar 2022
HOLDINGS NOW
81,497
AVG SELL PX
$90.99
TRADE KIND
SHOWING 30 / 30
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Elimelech Rosner, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+75.00%-3.37%+0.78%-4.15%-4.08%
14d8+62.50%-3.28%+1.05%-4.33%-5.79%
30d8+50.00%-1.79%+2.02%-3.81%-2.28%
60d8+50.00%-1.07%+4.60%-5.67%-4.50%
90d8+50.00%+0.32%+5.61%-5.29%-4.96%
180d8+37.50%+6.84%+11.77%-4.93%-4.90%
1y8(1 pending)+28.57%+8.58%+24.63%-16.05%-11.65%
2y8(5 pending)+0.00%+43.45%+50.75%-7.30%-16.71%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HQY · 81,497 shares · as of Apr 6, 2026
047,39294,784142,175189,5672023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 7 buys / 23 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
4,768$83.84$399.7K81,497Apr 6, 2026Apr 8, 2026View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
18,010$82.53$1.49M86,265Mar 31, 2026Apr 2, 2026View →
HQY
HEALTHEQUITY, INC.
PURCHASEGRANT
Stock grant
19,70463,372Mar 25, 2026Mar 27, 2026View →
HQY
HEALTHEQUITY, INC.
PURCHASEGRANT
Stock grant
40,903104,275Mar 25, 2026Mar 27, 2026View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
2,074$95.24$197.5K43,668Jan 9, 2026Jan 13, 2026View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
10,959$95.45$1.05M45,742Dec 18, 2025Dec 19, 2025View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
3,006$88.57$266.2K56,701Oct 6, 2025Oct 8, 2025View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
2,982$100.87$300.8K59,707Jul 3, 2025Jul 8, 2025View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
13,000$111.37$1.45M62,689Jun 9, 2025Jun 10, 2025View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
58,000$112.56$6.53M75,689Jun 6, 2025Jun 10, 2025View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
52,078$79.88$4.16M133,689Apr 8, 2025Apr 10, 2025View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
3,800$83.88$318.7K185,767Apr 3, 2025Apr 4, 2025View →
HQY
HEALTHEQUITY, INC.
PURCHASEGRANT
Stock grant
16,90372,391Apr 2, 2025Apr 4, 2025View →
HQY
HEALTHEQUITY, INC.
PURCHASEGRANT
Stock grant
117,176189,567Apr 2, 2025Apr 4, 2025View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
1,707$97.54$166.5K55,488Jan 7, 2025Jan 9, 2025View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
2,869$97.12$278.6K57,195Dec 12, 2024Dec 13, 2024View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
2,456$78.25$192.2K60,064Oct 3, 2024Oct 7, 2024View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
12,296$77.02$947.1K62,520Sep 6, 2024Sep 10, 2024View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
747$83.68$62.5K74,816Jul 3, 2024Jul 5, 2024View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
1,727$83.68$144.5K75,563Jul 3, 2024Jul 5, 2024View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
3,209$80.60$258.6K77,290Apr 3, 2024Apr 4, 2024View →
HQY
HEALTHEQUITY, INC.
PURCHASEGRANT
Stock grant
18,81680,499Mar 27, 2024Mar 29, 2024View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
1,215$67.64$82.2K61,683Jan 5, 2024Jan 9, 2024View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
2,017$70.09$141.4K62,898Dec 11, 2023Dec 13, 2023View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
1,701$72.06$122.6K64,915Oct 4, 2023Oct 6, 2023View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
1,998$71.92$143.7K66,616Sep 22, 2023Sep 26, 2023View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
10,156$64.29$652.9K70,334Jun 12, 2023Jun 12, 2023View →
HQY
HEALTHEQUITY, INC.
SALE
EVP, CHIEF TECHNOLOGY OFFICER
4,715$55.99$264.0K80,490Apr 4, 2023Apr 5, 2023View →
HQY
HEALTHEQUITY, INC.
PURCHASEGRANT
Stock grant
25,72585,205Mar 29, 2023Mar 30, 2023View →
HQY
HEALTHEQUITY, INC.
PURCHASEGRANT
Stock grant
59,48059,480Mar 30, 2022Apr 1, 2022View →
Other insiders · HQY
Loading peer insiders…
About this filer
CIK 0001916312
ROLE
EVP, CHIEF TECHNOLOGY OFFICER
PRIMARY
HQY
COMPANIES
1
ACTIVE SINCE
Mar 2022
MARKETPEEL · /INSIDER/0001916312DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback